login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
LUCID DIAGNOSTICS INC (LUCD) Stock News
NASDAQ:LUCD -
US54948X1090
-
Common Stock
1.1
USD
+0.05 (+4.76%)
Last: 8/22/2025, 8:21:34 PM
1.13
USD
+0.03 (+2.73%)
After Hours:
8/22/2025, 8:21:34 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
LUCD Latest News, Press Relases and Analysis
All
Press Releases
11 days ago - By: Chartmill
LUCID DIAGNOSTICS INC (NASDAQ:LUCD) Reports Q2 2025 Earnings In Line with Estimates, Narrower Loss Than Expected
11 days ago - By: Zacks Investment Research
- Mentions:
ELMD
Lucid Diagnostics Inc. (LUCD) Reports Q2 Loss, Tops Revenue Estimates
12 days ago - By: The Motley Fool
LUCD Reports Results
12 days ago - By: Lucid Diagnostics
- Mentions:
PAVM
Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results
12 days ago - By: Benzinga
- Mentions:
CMCT
CINT
RDCM
HYPR
...
Earnings Scheduled For August 13, 2025
12 days ago - By: Zacks Investment Research
- Mentions:
RPID
Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Misses Revenue Estimates
17 days ago - By: Zacks Investment Research
- Mentions:
INGN
Inogen (INGN) Reports Q2 Loss, Beats Revenue Estimates
19 days ago - By: Zacks Investment Research
- Mentions:
MLAB
Mesa Labs (MLAB) Lags Q1 Earnings and Revenue Estimates
25 days ago - By: PAVmed Inc.
- Mentions:
PAVM
PAVmed to Hold a Business Update Conference Call and Webcast on August 14, 2025
26 days ago - By: PAVmed Inc.
- Mentions:
PAVM
PAVmed Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
a month ago - By: Lucid Diagnostics
- Mentions:
PAVM
MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA Test
2 months ago - By: Lucid Diagnostics
- Mentions:
PAVM
Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' EsoGuard® Esophageal DNA Test
3 months ago - By: Lucid Diagnostics
- Mentions:
PAVM
Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes
3 months ago - By: PAVmed Inc.
- Mentions:
PAVM
PAVmed Provides Business Update and Reports First Quarter 2025 Financial Results
3 months ago - By: Zacks Investment Research
Lucid Diagnostics Inc. (LUCD) Reports Q1 Loss, Lags Revenue Estimates
3 months ago - By: Lucid Diagnostics
- Mentions:
PAVM
Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results
3 months ago - By: Benzinga
A Glimpse of Lucid Diagnostics's Earnings Potential
3 months ago - By: Zacks Investment Research
- Mentions:
MASS
908 Devices Inc. (MASS) Reports Q1 Loss, Misses Revenue Estimates
3 months ago - By: Zacks Investment Research
- Mentions:
STXS
Stereotaxis Inc. (STXS) Reports Q1 Loss, Tops Revenue Estimates
4 months ago - By: Zacks Investment Research
- Mentions:
MASS
Will Lucid Diagnostics Inc. (LUCD) Report Negative Earnings Next Week? What You Should Know
4 months ago - By: PAVmed Inc.
- Mentions:
PAVM
PAVmed to Hold a Business Update Conference Call and Webcast on May 15, 2025
4 months ago - By: Lucid Diagnostics
- Mentions:
PAVM
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025
4 months ago - By: Lucid Diagnostics
- Mentions:
PAVM
NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics' EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD
5 months ago - By: Lucid Diagnostics
- Mentions:
PAVM
Lucid Diagnostics Announces Closing of Public Offering of Common Stock
5 months ago - By: Lucid Diagnostics
- Mentions:
PAVM
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock
Please enable JavaScript to continue using this application.